Diebold Nixdorf, Incorporated (DBD) Cash Flow Statement

The wide fluctuation in OCF/NI, from -1.35 in Q2 2026 to 35.04 in Q4 2024, suggests that net income is not a reliable indicator of cash generation. The large positive working capital changes in Q4 2025 ($151.6M) and Q4 2024 ($171.1M) appear to be seasonal or project-related, inflating operating cash flow in those quarters. Investors should monitor whether these swings reflect sustainable operational efficiency or merely timing of collections and payables.

The FCF trajectory is highly erratic, with negative FCF in three of the last ten quarters and a dramatic spike in Q4 2025. This pattern suggests that the company's cash conversion is not smooth, and the Q4 spikes may be driven by one-time working capital releases. The average FCF margin across the period is roughly 3.5%, which is modest and below the peer NCR Atleos's 2.4% but still positive. However, the volatility implies that investors should not extrapolate recent strong quarters as a new norm.

CapEx/Revenue ratios have remained consistently below 2%, which is low for a technology and services company. This may indicate that DBD is in a maintenance phase, spending only to replace assets rather than expand capacity. The low capital intensity could be a positive for free cash flow, but it also raises questions about whether the company is investing enough to support future growth, especially given the sluggish revenue growth noted in the income statement analysis.

The working capital changes are highly volatile, with large positive contributions in Q4 quarters and negative in others. This pattern suggests that DBD may have significant seasonal contracts or project-based revenue that causes lumpy cash collections. The negative working capital changes in Q1 and Q2 of 2026 (-$12.2M and $4.9M) indicate that the company is using cash to fund operations, which may be a concern if it persists. Investors should monitor whether management can smooth these swings through better working capital management.

The buyback figures show a peculiar pattern: positive $60.4M in Q2 2026 and negative $60.4M in Q1 2026, which may indicate that the company is engaging in share repurchase programs but also issuing shares for employee compensation or other purposes. The net effect over the last two quarters is zero, suggesting that the company is not consistently returning capital to shareholders. Dividends are zero throughout, so the primary capital return mechanism appears to be buybacks, but the volatility in these numbers warrants further investigation.

The cumulative operating cash flow of $461.7M is significantly higher than cumulative net income of $98.6M, which suggests that the company has been able to convert earnings into cash effectively, but this is largely due to working capital inflows in Q4 quarters. The cumulative free cash flow of $382.5M is also strong, but the volatility in quarterly figures indicates that this is not a steady-state performance. Investors should be cautious about relying on the cumulative figures, as they may be skewed by one-time working capital benefits.